Simplex Trading
SURF

Simplex Trading’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Simplex Trading’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,400
Closed -$1K – 10319
2023
Q1 		$1K Sell
2,400
-1,900
-44% -$1.54K ﹤0.01% 8850
2022
Q4 		$3K Buy
4,300
+400
+10% +$394 ﹤0.01% 8483
2022
Q3 		$4K Sell
3,900
-300
-7% -$479 ﹤0.01% 9008
2022
Q2 		$6K Hold
4,200
– – ﹤0.01% 8773
2022
Q1 		$12K Sell
4,200
-5,800
-58% -$20.3K ﹤0.01% 8764
2021
Q4 		$47K Sell
10,000
-19,800
-66% -$128K ﹤0.01% 7353
2021
Q3 		$219K Sell
29,800
-200
-0.7% -$1.28K ﹤0.01% 5453
2021
Q2 		$223K Buy
30,000
+29,581
+7,060% +$228K ﹤0.01% 5519
2021
Q1 		$326K Buy
+419
New +$4.19K ﹤0.01% 4041

Simplex Trading's SURF Position: Q3 2023 in Review

Simplex Trading sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 20,332 shares — an estimated $17K sold.

Simplex Trading first reported a position in SURF in Q3 2020 and held it in 11 quarters. The position peaked at $119K in Q1 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Simplex Trading reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 20,332 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $17K.
  • Simplex Trading first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Simplex Trading's Surface Oncology, Inc. Common Stock position peaked at $119K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.